North America is expected to dominate the global HIV-Associated lipodystrophy market shortly and this is due to the fact the region is accounted for the high prevalence of HIV in the region. According to HIV.gov, an estimated 36,400 new HIV infections occurred in the United States in 2018. In 2018, 37,968 people received an HIV diagnosis in the U.S. and 6 dependent areas—an overall 7% decrease compared with 2014.
HIV-associated lipodystrophy is a disease of the lymphatic system, usually of the lymphatic system. It is caused by the virus called AIDS. Lipodystrophy can occur in the form of a group of diseases or just one disease. Lipodystrophy cannot be inherited by an individual. However, lipodystrophy can develop in an individual after becoming infected with HIV if he or she has developed a compatible virus already.AIDS may take nine long years to develop in an individual. This is why it is very difficult to detect the early stages of HIV-associated lipodystrophy. It may only manifest during the later stages of HIV infection. This is why it is also very important for the HIV-positive person to always have a yearly examination with his or her health specialist to monitor his or her health progress... Read more